A detailed history of Voya Investment Management LLC transactions in Geron Corp stock. As of the latest transaction made, Voya Investment Management LLC holds 171,947 shares of GERN stock, worth $729,055. This represents 0.0% of its overall portfolio holdings.

Number of Shares
171,947
Previous 204,125 15.76%
Holding current value
$729,055
Previous $430,000 31.86%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.75 - $3.44 $56,311 - $110,692
-32,178 Reduced 15.76%
171,947 $567,000
Q4 2023

Feb 14, 2024

BUY
$1.74 - $2.31 $6,752 - $8,965
3,881 Added 1.94%
204,125 $430,000
Q3 2023

Nov 14, 2023

BUY
$2.11 - $3.28 $4,960 - $7,711
2,351 Added 1.19%
200,244 $424,000
Q2 2023

Aug 14, 2023

BUY
$1.97 - $3.69 $76,526 - $143,341
38,846 Added 24.42%
197,893 $635,000
Q1 2023

May 15, 2023

SELL
$2.14 - $3.4 $1.86 Million - $2.95 Million
-867,417 Reduced 84.51%
159,047 $345,000
Q4 2022

Feb 14, 2023

BUY
$2.03 - $2.42 $1.8 Million - $2.15 Million
887,665 Added 639.53%
1,026,464 $2.48 Million
Q3 2022

Mar 03, 2023

SELL
$1.67 - $2.94 $1.48 Million - $2.61 Million
-887,665 Reduced 86.48%
138,799 $324,000
Q2 2022

Aug 15, 2022

BUY
$1.19 - $1.65 $23,120 - $32,057
19,429 Added 16.28%
138,799 $215,000
Q4 2021

Feb 14, 2022

SELL
$1.22 - $1.72 $247 - $349
-203 Reduced 0.17%
119,370 $146,000
Q2 2021

Aug 16, 2021

SELL
$1.25 - $1.83 $11,740 - $17,187
-9,392 Reduced 7.28%
119,573 $169,000
Q1 2021

May 17, 2021

BUY
$1.52 - $2.1 $9,223 - $12,742
6,068 Added 4.94%
128,965 $204,000
Q4 2020

Feb 16, 2021

BUY
$1.55 - $2.05 $47,992 - $63,474
30,963 Added 33.68%
122,897 $195,000
Q3 2020

Nov 16, 2020

BUY
$1.59 - $2.19 $44,138 - $60,794
27,760 Added 43.26%
91,934 $160,000
Q2 2020

Aug 14, 2020

SELL
$1.05 - $2.18 $30,135 - $62,566
-28,700 Reduced 30.9%
64,174 $140,000
Q4 2019

Feb 14, 2020

BUY
$1.27 - $1.54 $23,638 - $28,664
18,613 Added 25.06%
92,874 $126,000
Q2 2019

Aug 14, 2019

BUY
$1.37 - $2.02 $12,405 - $18,291
9,055 Added 13.89%
74,261 $105,000
Q2 2018

Aug 14, 2018

SELL
$3.29 - $4.82 $23,549 - $34,501
-7,158 Reduced 9.89%
65,206 $224,000
Q1 2018

May 15, 2018

SELL
$1.81 - $5.98 $12,823 - $42,368
-7,085 Reduced 8.92%
72,364 $308,000
Q3 2017

Nov 14, 2017

BUY
$1.99 - $2.65 $158,103 - $210,539
79,449
79,449 $173,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.6B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.